# Healthcare AI's Next Test is Integration
Major technology companies entering healthcare through artificial intelligence represents a watershed moment for an industry starved of computational innovation. OpenAI, Google DeepMind, Anthropic, and others have begun deploying models specifically trained on medical data. These systems excel at tasks that consume massive amounts of clinician time: parsing years of patient records, extracting relevant symptoms from dense documentation, cross-referencing treatments against current medical literature, and generating coherent clinical summaries that physicians can act on immediately.
The technical capability exists. Modern large language models trained on medical datasets can now process clinical documents at scale without hallucinating dangerous nonsense. They understand medical terminology with genuine nuance rather than surface-level pattern matching. They compare patient cases against evidence bases faster than any human could manually search. For an industry where administrative burden consumes roughly one-third of clinician time, these capabilities represent genuine relief.
But capability and integration are different problems.
The healthcare system operates through byzantine layers of legacy infrastructure, regulatory requirements, and institutional incentives that were built without AI in mind. A model that works brilliantly in a laboratory setting faces a different world inside a hospital's electronic health record system, compliance framework, and liability structure.
Integration requires solving for interoperability first. Most hospitals run disparate EHR systems from vendors like Epic, Cerner, and Medidata. These systems rarely talk cleanly to each other, let alone to external AI models. A clinician at one facility cannot easily share a patient's complete history with another provider. For AI to add value, it must pull data from fragmented sources, standardize it, and return results in formats each system can ingest and act upon. This remains technically solvable but organizationally complex.
The second barrier is regulatory uncertainty. The FDA has begun establishing pathways for AI-assisted diagnostic tools, but the framework remains in motion. Healthcare systems move cautiously when regulatory risk exists. They require clear liability assignments. If an AI system makes a recommendation that leads to patient harm, who bears responsibility? The vendor? The hospital? The clinician who acted on the output? Until these questions have legal answers, adoption stays constrained to pilots and low-stakes applications.
The third barrier is trust validation. Clinicians did not train on these models. They cannot easily assess whether an AI system's reasoning matches accepted medical standards or whether it is confidently wrong. Explainability tools exist but remain underdeveloped for medical contexts. A cardiologist needs to understand not just the model's output but its reasoning. Without that transparency, adoption stalls.
The fourth barrier is data governance. Patient data remains among the most sensitive information any organization handles. Feeding years of patient records into external AI systems raises legitimate privacy and security concerns. On-premise deployment and federated learning models exist as alternatives, but they introduce new technical complexity and cost.
These are not problems that better models alone solve. OpenAI's latest model might process medical data with higher accuracy, but it will not simplify EHR integration, rewrite FDA guidance, build clinician trust, or solve data governance. Integration requires infrastructure work: standardized APIs, clear regulatory pathways, explainability tools, and privacy-first deployment architectures.
The companies with the best technical models may not be the ones that succeed in healthcare. Success goes to whoever solves integration first.